Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-16 Sale | 2024-01-18 4:45 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 1,597 | $59.02 | $94,255 | 117,028 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:38 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer | 1,597 | $59.02 | $94,255 | 155,927 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 5:54 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,090 | $58.92 | $123,143 | 118,625 (Direct) | View |
| 2024-01-04 Sale | 2024-01-05 5:34 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer | 1,531 | $58.81 | $90,038 | 157,135 (Direct) | View |
| 2023-12-18 Sale | 2023-12-19 4:59 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer | 2,387 | $57.5 | $137,253 | 141,645 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 5:05 pm | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 2,220 | $56.67 | $125,807 | 103,694 (Direct) | View |
| 2023-09-08 Sale | 2023-09-12 5:41 pm | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer | 2,388 | $35.63 | $85,084 | 144,032 (Direct) | View |
| 2023-08-11 Purchase | 2023-08-15 9:39 pm | Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Dissanayake Shehan Bharatha Fuglesang Christopher See remarks | 1,258,973 | $27.8 | $34,999,449 | 6,672,789 (Indirect Direct) | View |
| 2023-08-11 Purchase | 2023-08-15 9:38 pm | Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Dissanayake Shehan Bharatha Fuglesang Christopher See remarks | 1,258,973 | $27.8 | $34,999,449 | 6,672,789 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-23 Disposition | 2024-01-25 4:32 pm | 2017-11-20 N/A | Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. Dissanayake Shehan Bharatha Fuglesang Christopher Braslyn Ltd. Lockend Five LLC See remarks | 12,183,864 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:38 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 23,742 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:38 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director | 18,772 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:38 pm | N/A 2028-12-05 | Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director | 97,845 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2027-05-16 | Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director | 45,793 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2026-05-17 | Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director | 73,793 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2027-04-30 | Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director | 80,468 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2033-01-19 | Mirati Therapeutics Inc. | MRTX | Ondrey Aaron Chief Financial Officer | 63,298 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2033-05-01 | Mirati Therapeutics Inc. | MRTX | Moriarty John B Chief Legal Officer | 155,860 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2033-01-20 | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 162,484 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2028-12-05 | Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director | 53,293 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2032-11-06 | Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer | 144,865 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2027-01-25 | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer | 468,410 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2027-01-25 | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M Founder, President, and CEO | 956,084 | $0 | 0 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2033-06-21 | Mirati Therapeutics Inc. | MRTX | Gallagher Carol Giltner Director | 27,147 | $0 | 0 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 8:50 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director | 6,808 | $58.75 | 54,325 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:37 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director | 6,808 | $58.75 | 17,273 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:32 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director | 6,808 | $58.75 | 17,273 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:27 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Gallagher Carol Giltner Director | 6,808 | $58.75 | 14,363 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:24 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director | 6,808 | $58.75 | 16,222 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:22 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director | 6,808 | $58.75 | 11,252 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:18 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director | 9,702 | $58.75 | 24,752 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:16 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director | 6,808 | $58.75 | 17,273 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:13 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer | 17,021 | $58.75 | 120,715 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:05 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP & Chief Scientific Officer | 17,021 | $58.75 | 158,666 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:01 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer | 17,021 | $58.75 | 79,318 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 5:55 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Ondrey Aaron CFO | 17,021 | $58.75 | 39,461 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 5:52 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M Interim CEO | 20,425 | $58.75 | 247,700 (Direct) | View |
Ownership | 2023-12-27 4:04 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | EcoR1 Capital LLC 10% Owner | 0 | $0 | 7,396,979 (Indirect) | View |
| 2023-09-08 Option Award | 2023-09-12 5:30 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Ondrey Aaron Interim CFO | 8,412 | $35.66 | 22,440 (Direct) | View |
Ownership | 2023-09-12 5:27 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Ondrey Aaron Interim CFO | 0 | $0 | 37,805 (Direct) | View |